Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries.
- DOI
- 10.1016/j.esmoop.2025.105855
- Published
- 2025 Nov
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.105855,
title = {Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries.},
author = {Rosenberg N and Post HC and Schutte T and de Visser SJ and Bartelink I and Pasmooij AMG and van Laarhoven HWM and Hollak CEM},
year = {2025},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2025.105855},
url = {https://doi.org/10.1016/j.esmoop.2025.105855}
}RIS
TY - JOUR TI - Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries. AU - Rosenberg N AU - Post HC AU - Schutte T AU - de Visser SJ AU - Bartelink I AU - Pasmooij AMG AU - van Laarhoven HWM AU - Hollak CEM PY - 2025 JO - ESMO open DO - 10.1016/j.esmoop.2025.105855 UR - https://doi.org/10.1016/j.esmoop.2025.105855 ER -
APA
N, R., HC, P., T, S., SJ, D. V., I, B., AMG, P., HWM, V. L., & CEM, H. (2025). Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries.. ESMO open. https://doi.org/10.1016/j.esmoop.2025.105855
Source records
- pubmed · retrieved 2026-09-25T20:24:23.165Z